Found: 41
Select item for more details and to access through your institution.
VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
- Published in:
- Journal of Gene Medicine, 2005, v. 7, n. 3, p. 375, doi. 10.1002/jgm.679
- By:
- Publication type:
- Article
Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER‐MRI studies.
- Published in:
- Pulmonary Circulation, 2024, v. 14, n. 2, p. 1, doi. 10.1002/pul2.12386
- By:
- Publication type:
- Article
Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 4, p. 1, doi. 10.1002/pul2.12136
- By:
- Publication type:
- Article
Pulmonary Vascular Research Institute GoDeep: A meta‐registry merging deep phenotyping datafrom international PH reference centers.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12123
- By:
- Publication type:
- Article
Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2019, v. 9, n. 4, p. 1, doi. 10.1177/2045894019890549
- By:
- Publication type:
- Article
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.
- Published in:
- Pulmonary Circulation, 2019, v. 9, n. 2, p. N.PAG, doi. 10.1177/2045894019848649
- By:
- Publication type:
- Article
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project.
- Published in:
- Pulmonary Circulation, 2018, v. 8, n. 4, p. 1, doi. 10.1177/2045894018798613
- By:
- Publication type:
- Article
Selective improvement of pulmonary arterial hypertension with a dual ET<sub>A</sub>/ET<sub>B</sub> receptors antagonist in the apolipoprotein E<sup>−/−</sup> model of PAH and atherosclerosis.
- Published in:
- Pulmonary Circulation, 2018, v. 8, n. 1, p. 1, doi. 10.1177/2045893217752328
- By:
- Publication type:
- Article
Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling.
- Published in:
- Pulmonary Circulation, 2017, v. 7, n. 4, p. 768, doi. 10.1177/2045893217729096
- By:
- Publication type:
- Article
Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2012, v. 2, n. 1, p. 21, doi. 10.4103/2045-8932.94819
- By:
- Publication type:
- Article
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Unsupervised machine learning to investigate trajectory patterns of COVID-19 symptoms and physical activity measured via the MyHeart Counts App and smart devices.
- Published in:
- NPJ Digital Medicine, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s41746-023-00974-w
- By:
- Publication type:
- Article
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-31095-0
- By:
- Publication type:
- Article
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00891-1
- By:
- Publication type:
- Article
Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00891-1
- By:
- Publication type:
- Article
A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2021, v. 22, n. 2, p. 236, doi. 10.1093/ehjci/jeaa001
- By:
- Publication type:
- Article
Expression Quantitative Trait Locus Mapping in Pulmonary Arterial Hypertension.
- Published in:
- Genes, 2020, v. 11, n. 11, p. 1247, doi. 10.3390/genes11111247
- By:
- Publication type:
- Article
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
No Evidence for Cardiac Dysfunction in Kif6 Mutant Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054636
- By:
- Publication type:
- Article
Ultrasound Gene Therapy: On the Road from Concept to Reality.
- Published in:
- Echocardiography, 2001, v. 18, n. 4, p. 339, doi. 10.1046/j.1540-8175.2001.00339.x
- By:
- Publication type:
- Article
Soluble P-Selectin and von Willebrand Factor Rise in Healthy Volunteers Following Non-exertional Ascent to High Altitude.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.825819
- By:
- Publication type:
- Article
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2017, v. 196, n. 11, p. 1478, doi. 10.1164/rccm.201701-0131LE
- By:
- Publication type:
- Article
Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.
- Published in:
- 2015
- By:
- Publication type:
- case study
Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 2, p. 254, doi. 10.1164/rccm.201411-2061le
- By:
- Publication type:
- Article
Reduced MicroRNA-150 Is Associated with Poor Survival in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 187, n. 3, p. 294, doi. 10.1164/rccm.201205-0839oc
- By:
- Publication type:
- Article
Frataxin and endothelial cell senescence in pulmonary hypertension.
- Published in:
- 2021
- By:
- Publication type:
- journal article
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Maintained right ventricular pressure overload induces ventricular-arterial decoupling in mice.
- Published in:
- Experimental Physiology, 2017, v. 102, n. 2, p. 180, doi. 10.1113/EP085963
- By:
- Publication type:
- Article
Zebrafish as a tractable model of human cardiovascular disease.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 5, p. 900, doi. 10.1111/bph.15473
- By:
- Publication type:
- Article
The role of chemokines and chemokine receptors in pulmonary arterial hypertension.
- Published in:
- British Journal of Pharmacology, 2021, v. 178, n. 1, p. 72, doi. 10.1111/bph.14826
- By:
- Publication type:
- Article
Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling.
- Published in:
- Cardiovascular Research, 2013, v. 100, n. 2, p. 252, doi. 10.1093/cvr/cvt170
- By:
- Publication type:
- Article
Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 6, p. 1, doi. 10.1161/JAHA.123.032256
- By:
- Publication type:
- Article
Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123709
- By:
- Publication type:
- Article